Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer.
European Hematology Association (EHA) 2024 Hybrid Congress
Receive updates straight into your inbox
Rigel Pharmaceuticals, Inc.
611 Gateway Blvd
Suite 900
South San Francisco, CA 94080
Rigel Pharmaceuticals, Inc.
ir@rigel.com
EQ Shareowner Services
T: 800-401-1957